Skip Ribbon Commands
Skip to main content
A- A A+

Find a Doctor

Dr Daniel Huang

Photo of Dr Daniel Huang
Tel:
+65 6908 2222
URL:
https://www.nuh.com.sg/medicine
https://www.nuh.com.sg/nucot
Designations:
  • Consultant, Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital
  • Consultant, Adult Liver Transplantation Programme, National University Centre for Organ Transplantation, National University Hospital
  • Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
Qualifications:
MBBS (S'pore), MMED (Int Med)(S'pore), MRCP (UK)
Specialties:
Medicine, Organ Transplantation
Sub-Specialties:
Adult Liver Transplantation Programme, Gastroenterology ＆ Hepatology
Special Interests:
 ​

Biosketch

Dr Daniel Huang graduated from the Yong Loo Lin School of Medicine, National University of Singapore, and did his postgraduate residency training in NUH. He completed his fellowship in Gastroenterology and Hepatology, and was certified by the Specialist Accreditation Board of Singapore.

Dr Huang has a keen interest in liver transplantation, and is a member of the liver transplant team at the National University Hospital, Singapore. He is also proficient in diagnostic and therapeutic endoscopy.

Dr Huang’s research interest is in hepatocellular carcinoma oncogenesis in the setting of NAFLD and hepatitis B, and performs translational and clinical research in these areas.

Area of Interest:

  • Hepatocellular carcinoma
  • Liver transplantation
  • Non-alcoholic fatty liver disease
  • Hepatitis B

Awards

​Yong Loo Lin School of Medicine Junior Doctor Teaching Award

  • Best oral presentation (GiHep)
  • Best oral presentation (UMC Academic Day)
  • Best oral presentation (NCSP)

Journals & Publications

  1. Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El-Serag, H. B., & Loomba, R. (2022). Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metabolism, 34(7), 969-977.e2. doi:10.1016/j.cmet.2022.05.003
  2. Tan, D. J. H., Ng, C. H., Tay, P. W. L., Syn, N., Muthiah, M. D., Lim, W. H., . . . Huang, D. Q. (2022). Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis.. JAMA Netw Open, 5(6), e2219407. doi:10.1001/jamanetworkopen.2022.19407
  3. Tan, D. J. H., Ng, C. H., Lin, S. Y., Pan, X. H., Tay, P., Lim, W. H., . . . Huang, D. Q. (2022). Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. The Lancet Oncology, 23(4), 521-530. doi:10.1016/S1470-2045(22)00078-X
  4. Huang, D. Q., Fowler, K. J., Liau, J., Cunha, G. M., Louie, A. L., An, J. Y., . . . Loomba, R. (2022). Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(7), 820-827. doi:10.1111/apt.16844
  5. Tan, D. J. H., Lim, W. H., Yong, J. N., Ng, C. H., Muthiah, M. D., Tan, E. X., . . . Huang, D. Q. (2022). UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2022.02.018
  6. Tan, E. X. -X., Quek, W. L., Suryadi., Chahed, H., Iyer, S. G., Jeyaraj, P. R., . . . Huang, D. Q. (2021). Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 16, 9 pages. doi:10.1016/j.lanwpc.2021.100262
  7. Huang, D. Q., Hoang, J. K., Leong, J., Riveiro-Barciela, M., Maeda, M., Yang, J. D., . . . Nguyen, M. H. (2021). Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma. LIVER INTERNATIONAL, 41(8), 1922-1932. doi:10.1111/liv.14877
  8. Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021). Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.. Nature reviews. Gastroenterology & hepatology, 18(4), 223-238. doi:10.1038/s41575-020-00381-6
  9. Huang, D. Q., Muthiah, M. D., Zhou, L., Jumat, H., Tan, W. X., Lee, G. H., . . . Dan, Y. Y. (2021). Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 11(5), 1313-1325. doi:10.1016/j.jcmgh.2020.12.009
  10. Huang, D. Q., Li, X., Le, M. H., Le, A. K., Yeo, Y. H., Trinh, H. N., . . . Nguyen, M. H. (2021). Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2021.01.019



Professional Memberships

  • ​Gastroenterological Society of Singapore (GESS)
  • Member of the Royal College of Physicians (UK)

National University Health System
  • National University Hospital
  • Ng Teng Fong General Hospital
  • Alexandra Hospital
  • Jurong Community Hospital
  • National University Polyclinics
  • Jurong Medical Centre
  • National University Cancer Institute, Singapore
  • National University Heart Centre, Singapore
  • National University Centre for Oral Health, Singapore (NUCOHS)
  • NUHS Diagnostics
  • NUHS Pharmacy logo
  • Blank White Space
  • NUS - Yong Loo Lin, School of Medicine
  • NUS - Faculty of Dentistry
  • NUS - Saw Swee Hock, School of Public Health

 

Back to Top